SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000711377-24-000013
Filing Date
2024-05-03
Accepted
2024-05-03 16:27:02
Documents
1
Period of Report
2024-04-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3282
  Complete submission text file 0000711377-24-000013.txt   4674
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 822 7TH STREET, SUITE 740 GREELEY CO 80631
Business Address
ADENT JOHN EDWARD (Reporting) CIK: 0001651434 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-17988 | Film No.: 24913578